[1] BRAY F, FERLAY J, SOERJOMATARAM I, et al.Global Cancer Statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2018, 68(6):394424.
[2] CHEN WQ, ZHENG RS, BAADE PD, et al.Cancer statistics in China, 2015[J].CA Cancer J Clin, 2016, 66(2):115. doi: 10.3322/caac.21338
[3] HUANG X, GOLLIN SM, RAJA S, et al.High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells[J].Proc Natl Acad Sci U S A, 2002, 99(17):11369. doi: 10.1073/pnas.172285799
[4] JIANG L, ZENG X, WANG Z, et al.Oral cancer overexpressed 1(ORAOV1)regulated cell cycle and apoptosis in cervical cancer HeLa cells[J].Mol Cancer, 2010, 9:20. doi: 10.1186/1476-4598-9-20
[5] TOGASHI Y, ARAO T, KATO H, et al.Frequent amplification of ORAOV1 gene in esophageal squamous cell cancer promotes an aggressive phenotype via proline metabolism and ROS production[J].Oncotarget, 2014, 5(10):2962. doi: 10.18632/oncotarget.1561
[6] WATANABE K, HASEGAWA Y, YAMASHITA H, et al.Vasohibin as an endothelium-derived negative feedback regulator of angiogenesis[J].J Clin Invest, 2004, 114(7):898. doi: 10.1172/JCI200421152
[7] AFFARA M, SANDERS D, ARAKI H, et al.Vasohibin-1 is identified as a master-regulator of endothelial cell apoptosis using gene network analysis[J].BMC Genomics, 2013, 14:23. doi: 10.1186/1471-2164-14-23
[8] HEISHI T, HOSAKA T, SUZUKI Y, et al.Endogenous angiogenesis inhibitor vasohibin1 exhibits broad-spectrum antilymphangiogenic activity and suppresses lymph node metastasis[J].Am J Pathol, 2010, 176(4):1950. doi: 10.2353/ajpath.2010.090829
[9] KOSAKA T, MIYAZAKI Y, MIYAJIMA A, et al.The prognostic significance of vasohibin-1 expression in patients with prostate cancer[J].Br J Cancer, 2013, 108(10):2123. doi: 10.1038/bjc.2013.169
[10] WU S, YU L, WANG D, et al.Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry[J].BMC Cancer, 2012, 12:535. doi: 10.1186/1471-2407-12-535
[11] JIANG L, ZENG X, YANG H, et al.Oral cancer overexpressed 1(ORAOV1):a regulator for the cell growth and tumor angiogenesis in oral squamous cell carcinoma[J].Int J Cancer, 2008, 123(8):1779. doi: 10.1002/ijc.23734
[12] ZHAO X, LIU D, WANG L, et al.RNAi-mediated downregulation of oral cancer overexpressed 1(ORAOV1)inhibits vascular endothelial cell proliferation, migration, invasion, and tube formation[J].J Oral Pathol Med, 2016, 45(4):256. doi: 10.1111/jop.12371
[13] LI M, CUI X, SHEN Y, et al.ORAOV1 overexpression in esophageal squamous carcinoma and esophageal dysplasia:a possible biomarker of progression and poor prognosis in esophageal carcinoma[J].Hum Pathol, 2015, 46(5):707. doi: 10.1016/j.humpath.2015.01.009
[14] 冯吉, 刘琴, 刘磊, 等.口腔癌过表达蛋白1在结肠癌中的表达及其对细胞增殖、周期、凋亡的影响[J].第三军医大学学报, 2016, 38(10):1160.
[15] KERN J, BAUER M, RYCHLI K, et al.Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation[J].Arterioscler Thromb Vasc Biol, 2008, 28(3):478. doi: 10.1161/ATVBAHA.107.160432
[16] MIYAZAKI Y, KOSAKA T, MIKAMI S, et al.The prognostic significance of vasohibin-1 expression in patients with upper urinary tract urothelial carcinoma[J].Clin Cancer Res, 2012, 18(15):4145. doi: 10.1158/1078-0432.CCR-12-0073